Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 235Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Paladin Pharma Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Paladin Pharma Inc.

arrow
Peptide Process CMC
Not Confirmed

Paladin Pharma Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Doxepin Hydrochloride

Brand Name : SILENOR

Patent Number : 2693992

Filing Date : 2007-07-20

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-07-20

Date Granted : 2017-01-31

blank

02

Paladin Pharma Inc.

arrow
Peptide Process CMC
Not Confirmed

Paladin Pharma Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Doxepin Hydrochloride

Brand Name : SILENOR

Patent Number : 2721133

Filing Date : 2008-04-11

Strength per Unit : 3 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-04-11

Date Granted : 2018-11-06

blank

03

Paladin Pharma Inc.

arrow
Peptide Process CMC
Not Confirmed

Paladin Pharma Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Doxepin Hydrochloride

Brand Name : SILENOR

Patent Number : 2693992

Filing Date : 2007-07-20

Strength per Unit : 6 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2027-07-20

Date Granted : 2017-01-31

blank

04

Paladin Pharma Inc.

arrow
Peptide Process CMC
Not Confirmed

Paladin Pharma Inc.

Country
arrow
Peptide Process CMC
Not Confirmed

Doxepin Hydrochloride

Brand Name : SILENOR

Patent Number : 2721133

Filing Date : 2008-04-11

Strength per Unit : 6 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-04-11

Date Granted : 2018-11-06

blank